Kitazume-Taneike et al. showed that ablation of TLR9 attenuates myocardial ischaemia/reperfusion injury and inflammatory responses in mice, which is relevant since COVID-19 can lead to myocardial ischaemia and therefore tissue damage [150]. This evidence concerns the gene TLR9 and COVID-19.